1. Home
  2. CFND vs VRCA Comparison

CFND vs VRCA Comparison

Compare CFND & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CFND

C1 Fund Inc.

N/A

Current Price

$3.80

Market Cap

27.4M

Sector

N/A

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.05

Market Cap

87.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFND
VRCA
Founded
N/A
2013
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.4M
87.5M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
CFND
VRCA
Price
$3.80
$6.05
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$17.00
AVG Volume (30 Days)
22.7K
125.6K
Earning Date
N/A
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,577,000.00
Revenue This Year
N/A
$372.93
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$3.68
$0.39
52 Week High
$9.67
$9.82

Technical Indicators

Market Signals
Indicator
CFND
VRCA
Relative Strength Index (RSI) 43.21 51.31
Support Level $3.75 $5.22
Resistance Level $4.08 $6.44
Average True Range (ATR) 0.18 0.46
MACD 0.03 0.16
Stochastic Oscillator 40.28 70.51

Price Performance

Historical Comparison
CFND
VRCA

About CFND C1 Fund Inc.

C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Share on Social Networks: